Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Diamond Biofund Inc. is a biotechnology investment firm based in Taiwan, founded in 2013. It holds the distinction of being the first publicly listed sustainable biotech venture capital firm in Taiwan. The firm is dedicated to supporting innovative biotechnology companies by providing not only capital but also essential resources aimed at enhancing governance, technology development, clinical execution, and overall business growth.
As of now, Diamond Biofund manages a portfolio of over 20 companies, focusing on early-stage investments. The firm has established itself as a key player in the biotech sector, with a commitment to identifying and nurturing companies that possess international competitiveness and address unmet medical needs. Its operations extend globally, with a particular emphasis on the Asian market.
Diamond Biofund specializes in investments within the biotechnology and medical sectors, targeting global opportunities. The firm invests in various areas, including new drug development, advanced medical devices, innovative medical services, and agricultural biotechnology. Their investment strategy is designed to assist early-stage companies by providing not only capital but also strategic support across multiple operational aspects, including research and development, finance, and corporate governance.
The firm seeks to partner with companies that demonstrate potential for significant impact in the healthcare sector. Diamond Biofund emphasizes identifying startups that are addressing critical medical needs and have the potential for substantial growth. Their approach combines financial investment with operational guidance, ensuring that portfolio companies are well-equipped to navigate the complexities of the biotech landscape.
Diamond Biofund has invested in over 20 biotechnology startups, showcasing a diverse portfolio that includes:
This portfolio reflects Diamond Biofund's commitment to supporting companies that are at the forefront of biotechnology innovation, with a focus on enhancing healthcare outcomes.
Yang Pan-Chih - Chairman. Yang has extensive experience in the biotech sector and has played a pivotal role in establishing Diamond Biofund as a leader in sustainable biotech investments.
Lee Tsu-Te - Vice Chairman. Lee brings a wealth of knowledge in corporate governance and financial management, contributing to the firm's strategic direction.
Wu You-Mei - General Manager. Wu oversees daily operations and ensures that the firm effectively supports its portfolio companies.
Huang Yan-Zhen - Chief Financial Officer. Huang manages the financial aspects of the firm, focusing on investment strategies and financial reporting.
To pitch to Diamond Biofund, founders should visit their website at diamondbiofund.com. The firm prefers detailed pitch decks that clearly outline the business model, market opportunity, and operational strategies. While specific application forms were not mentioned, a well-prepared presentation is crucial. Response times may vary, so founders should be prepared for potential follow-up discussions.
In early March 2026, Diamond Biofund announced multiple updates regarding corporate governance and financial reporting. These announcements reflect the firm's commitment to transparency and operational excellence. The firm has been actively publishing blog posts that detail their investment activities and governance decisions, indicating a proactive approach to engaging with stakeholders.
What are Diamond Biofund's investment criteria?
Diamond Biofund focuses on early-stage biotechnology and healthcare companies, particularly those involved in drug development, medical devices, and innovative medical services. They seek startups that address unmet medical needs and demonstrate potential for significant growth.
How can I apply or pitch to Diamond Biofund?
Founders interested in pitching to Diamond Biofund can visit their website at diamondbiofund.com for more information on the application process. Specific email addresses for pitches were not provided.
What makes Diamond Biofund different from other investors?
Diamond Biofund is the first publicly listed sustainable biotech venture capital firm in Taiwan. Their unique approach combines financial investment with strategic operational support, enhancing governance and technology development for portfolio companies.
What is the geographic scope of Diamond Biofund's investments?
Diamond Biofund invests globally, with a particular focus on opportunities in Asia. They aim to support companies that have the potential to compete on an international scale.
What is the typical check size for investments?
While specific check sizes are not disclosed, Diamond Biofund invests in early-stage companies across various funding rounds, including Pre-seed, Seed, Seed+, and Series A.
What kind of post-investment involvement does Diamond Biofund have?
Diamond Biofund provides ongoing support to its portfolio companies, focusing on governance, technology development, and clinical execution to help them grow and succeed in the competitive biotech landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.